Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy

Infection by the human immune deficiency virus (HIV) is the strongest risk factor for latent or new infection of tuberculosis (TB) through reduction of CD4 T-lymphocytes and cellular immune function. Almost one-third of deaths among people living with HIV are attributed to tuberculosis. Despite this...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fassikaw Kebede, Tsehay Kebede, Birhanu Kebede, Abebe Abate, Dube Jara, Belete Negese, Tamrat Shaweno
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/b3aae823d8ed4238b7d0c2a75ca232de
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b3aae823d8ed4238b7d0c2a75ca232de
record_format	dspace
spelling	oai:doaj.org-article:b3aae823d8ed4238b7d0c2a75ca232de2021-11-22T01:11:19ZTime to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy2090-151810.1155/2021/6686019https://doaj.org/article/b3aae823d8ed4238b7d0c2a75ca232de2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/6686019https://doaj.org/toc/2090-1518Infection by the human immune deficiency virus (HIV) is the strongest risk factor for latent or new infection of tuberculosis (TB) through reduction of CD4 T-lymphocytes and cellular immune function. Almost one-third of deaths among people living with HIV are attributed to tuberculosis. Despite this evidence, in Ethiopia, there is a scarcity of information regarding the incidence of tuberculosis for children living with HIV. Thus, this study assessed time to develop and predictors for incidence of tuberculosis in children attending HIV/AIDS care in public hospitals: North West Ethiopia 2021. Methods. A facility-based retrospective cohort study was conducted among 421 seropositive children on antiretroviral therapy in two hospitals between January 1, 2011 and December 31, 2020. EPI-DATA version 3.2 and STATA/14 software were used for data entry and analysis, respectively. Tuberculosis-free survival time was estimated using the Kaplan-Meier survival curve. Bivariate and multivariable Cox regression model was fitted to identify predictors at a P value <0.05 within 95% CI. Results. In the final analysis, a total of 421 seropositive children were included, of whom, 64 (15.2%) developed tuberculosis at the time of follow-up. The mean (±SD) age of the children was 10.62±3.32 years, with a median (IQR) time to develop TB that was 23.5 (IQR=±19) months. This study found that the incidence of tuberculosis was 5.9 (95% CI: 4.7; 7.6) per 100 person-years (PY) risk of observation. Cases at baseline not taking cotrimoxazol preventive therapy (CPT) (AHR=2.5; 95% CI, 1.4-4.7, P<0.021), being severely stunted (AHR=2.9: 95% CI, 1.2-7.8, P<0.03), and having low hemoglobin level (AHR=4.0; 95% CI, 2.1-8.1, P<0.001) were found to be predictors of tuberculosis. Conclusion. A higher rate of tuberculosis incidence was reported in our study as compared with previous studies in Ethiopia. Cases at baseline not taking cotrimoxazol preventive therapy (CPT), being severely stunted, and having low hemoglobin (≤10 mg/dl) levels were found to be at higher risk to developed TB incidence.Fassikaw KebedeTsehay KebedeBirhanu KebedeAbebe AbateDube JaraBelete NegeseTamrat ShawenoHindawi LimitedarticleMedicineRENTuberculosis Research and Treatment, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Fassikaw Kebede Tsehay Kebede Birhanu Kebede Abebe Abate Dube Jara Belete Negese Tamrat Shaweno Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
description	Infection by the human immune deficiency virus (HIV) is the strongest risk factor for latent or new infection of tuberculosis (TB) through reduction of CD4 T-lymphocytes and cellular immune function. Almost one-third of deaths among people living with HIV are attributed to tuberculosis. Despite this evidence, in Ethiopia, there is a scarcity of information regarding the incidence of tuberculosis for children living with HIV. Thus, this study assessed time to develop and predictors for incidence of tuberculosis in children attending HIV/AIDS care in public hospitals: North West Ethiopia 2021. Methods. A facility-based retrospective cohort study was conducted among 421 seropositive children on antiretroviral therapy in two hospitals between January 1, 2011 and December 31, 2020. EPI-DATA version 3.2 and STATA/14 software were used for data entry and analysis, respectively. Tuberculosis-free survival time was estimated using the Kaplan-Meier survival curve. Bivariate and multivariable Cox regression model was fitted to identify predictors at a P value <0.05 within 95% CI. Results. In the final analysis, a total of 421 seropositive children were included, of whom, 64 (15.2%) developed tuberculosis at the time of follow-up. The mean (±SD) age of the children was 10.62±3.32 years, with a median (IQR) time to develop TB that was 23.5 (IQR=±19) months. This study found that the incidence of tuberculosis was 5.9 (95% CI: 4.7; 7.6) per 100 person-years (PY) risk of observation. Cases at baseline not taking cotrimoxazol preventive therapy (CPT) (AHR=2.5; 95% CI, 1.4-4.7, P<0.021), being severely stunted (AHR=2.9: 95% CI, 1.2-7.8, P<0.03), and having low hemoglobin level (AHR=4.0; 95% CI, 2.1-8.1, P<0.001) were found to be predictors of tuberculosis. Conclusion. A higher rate of tuberculosis incidence was reported in our study as compared with previous studies in Ethiopia. Cases at baseline not taking cotrimoxazol preventive therapy (CPT), being severely stunted, and having low hemoglobin (≤10 mg/dl) levels were found to be at higher risk to developed TB incidence.
format	article
author	Fassikaw Kebede Tsehay Kebede Birhanu Kebede Abebe Abate Dube Jara Belete Negese Tamrat Shaweno
author_facet	Fassikaw Kebede Tsehay Kebede Birhanu Kebede Abebe Abate Dube Jara Belete Negese Tamrat Shaweno
author_sort	Fassikaw Kebede
title	Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
title_short	Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
title_full	Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
title_fullStr	Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
title_full_unstemmed	Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy
title_sort	time to develop and predictors for incidence of tuberculosis among children receiving antiretroviral therapy
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/b3aae823d8ed4238b7d0c2a75ca232de
work_keys_str_mv	AT fassikawkebede timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy AT tsehaykebede timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy AT birhanukebede timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy AT abebeabate timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy AT dubejara timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy AT beletenegese timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy AT tamratshaweno timetodevelopandpredictorsforincidenceoftuberculosisamongchildrenreceivingantiretroviraltherapy
_version_	1718418301512581120

Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy

Ejemplares similares